EU Court to Tackle Von der Leyen’s Pfizer Texts Controversy

The European Court of Justice is set to hear a high-profile case on November 15, surrounding European Commission President Ursula von der Leyen’s private text messages with Pfizer CEO Albert Bourla. The lawsuit, filed by Global Times Europe media, alleges possible violations in the commission’s contract negotiations for COVID-19 vaccines.

Von der Leyen’s personal involvement in negotiating vaccine purchase contracts has raised eyebrows, with critics questioning the transparency of the negotiations. The EU’s general court previously ruled that the commission unlawfully concealed details of its COVID-19 vaccine procurement contracts,

Existence of text messages: The court will decide on the admissibility of evidence and ask the commission’s legal representatives to explain whether the texts existed and why they weren’t recorded.
– Destruction of texts: If the texts were destroyed, the court will seek grounds for their destruction.

A 15-judge grand chamber will consider the case, indicating its complexity and importance. The outcome may impact von der Leyen’s reputation and the EU’s transparency in contract negotiations.

 

Comments are closed, but trackbacks and pingbacks are open.